BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Epsilogen announces significant expansion of management team with three new senior hires

  Epsilogen Ltd, a global leader in the development of novel immunoglobulin E antibodies to treat cancer, announced three new senior hires in what is a significant expansion of their management team.

  April 26, 2023

   · 

  3 min read
• Business

  BioInvent International AB: Interim Report January-March 2023

  After the end of the quarter, we received very positive news in our BI-1206 project.

  April 26, 2023

   · 

  2 min read
• Business

  Mainz Biomed Announces Partnership with the Instituto de Microecologia to Expand ColoAlert® Commercialization in Spain and Portugal

  Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, announced that it has added the Instituto de Microecologia in Madrid to its growing network of lab partners across Europe and in select international markets.

  April 26, 2023

   · 

  6 min read
• Transfer of Nicox’s shares to Euronext Growth Paris effective on April 28, 2023

  Nicox SA announced that the transfer of the listing of the securities issued by the Company from the Euronext Paris regulated market to the Euronext Growth Paris multilateral trading facility, will be effective as from the trading session of April 28, 2023.

  April 26, 2023

   · 

  4 min read
• Business

  NRG Therapeutics Appoints Dr Jonathan Savidge as Independent Chair

  NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that it has appointed Jonathan Savidge Ph.D to its Board of Directors as an independent Non-Executive Chair.

  April 26, 2023

   · 

  3 min read
• Stallergenes Greer Foundation to Foster Innovation and Precision Medicine in the Field of Allergy

  Stallergenes Greer, a biopharmaceutical company specialising in the research, diagnosis and treatment of respiratory allergies, is pleased to announce its strategic direction for the Stallergenes Greer Foundation.

  April 26, 2023

   · 

  3 min read
• Business

  Integra LifeSciences Reports First Quarter 2023 Financial Results

  Integra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the first quarter ending March 31, 2023.

  April 26, 2023

   · 

  19 min read
• Business

  Leaders in Breast and Lung Cancer treatment join SystImmune Inc’s Clinical Science Advisory Committee

  SystImmune Inc. has announced the creation of its Clinical Science Advisory Committee, appointing Dr. Hope Rugo, M.D., Dr. Sara Tolaney, M.D., M.P.H, Dr. Pasi Jänne, M.D., Ph.D., MMSC.

  April 26, 2023

   · 

  7 min read
• Business

  United Therapeutics Corporation to Report First Quarter 2023 Financial Results Before the Market Opens on Wednesday, May 3, 2023

  United Therapeutics Corporation announced that it will report its first quarter 2023 financial results before the market opens on Wednesday, May 3, 2023.

  April 26, 2023

   · 

  2 min read
• Genetown

  Orbital Therapeutics Secures $270 Million in Series A Financing to Unleash Full Potential of RNA Medicines

  Orbital Therapeutics, a company focused on enhancing global health by unleashing the full potential of RNA medicines to treat human disease, announced the successful closing of $270 million Series A financing.

  April 26, 2023

   · 

  5 min read